Monitoring of Tobramycin Exposure: What is the Best Estimation Method and Sampling Time for Clinical Practice?

被引：0
|
作者：
Yanhua Gao
Stefanie Hennig
Michael Barras
机构：
[1] Pharmacy Australia Centre of Excellence,School of Pharmacy
[2] University of Queensland,undefined
[3] Princess Alexandra Hospital,undefined
来源：
Clinical Pharmacokinetics | 2019年 / 58卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：389 / 399
页数：10
相关论文
共 50 条
  • [1] Monitoring of Tobramycin Exposure: What is the Best Estimation Method and Sampling Time for Clinical Practice?
    Gao, Yanhua
    Hennig, Stefanie
    Barras, Michael
    CLINICAL PHARMACOKINETICS, 2019, 58 (03) : 389 - 399
  • [2] THE APPLICABILITY OF A LIMITED SAMPLING STRATEGY FOR ESTIMATION OF THE SYSTEMIC DRUG EXPOSURE OF TOBRAMYCIN IN CLINICAL PRACTICE
    Ritzmo, Carina
    Wallin, Carolina
    Svahn, Anita
    Soderhall, Stefan
    Eksborg, Staffan
    PEDIATRIC BLOOD & CANCER, 2010, 55 (05) : 972 - 973
  • [3] Best Practices to Implement Dried Blood Spot Sampling for Therapeutic Drug Monitoring in Clinical Practice
    Francke, Marith, I
    Peeters, Laura E. J.
    Hesselink, Dennis A.
    Kloosterboer, Sanne M.
    Koch, Birgit C. P.
    Veenhof, Herman
    de Winter, Brenda C. M.
    THERAPEUTIC DRUG MONITORING, 2022, 44 (05) : 696 - 700
  • [4] Monitoring antiplatelet therapy - What is the best method?
    Mukherjee, D
    Moliterno, DJ
    CLINICAL PHARMACOKINETICS, 2000, 39 (06) : 445 - 458
  • [5] What is the Best Sampling Method to Monitor the Effect of Endoscopy Reprocessing?
    Chung, Kwang Hyun
    Jang, Byung Ik
    CLINICAL ENDOSCOPY, 2018, 51 (05) : 397 - 398
  • [6] A comparison of prostate tumour volume estimation methods: which method is best in routine clinical practice?
    Perera, M.
    Bolton, D.
    Clouston, D.
    BJU INTERNATIONAL, 2012, 109 : 17 - 18
  • [7] A LIMITED SAMPLING STRATEGY FOR ESTIMATION OF THE TOBRAMYCIN AREA UNDER THE SERUM CONCENTRATION VERSUS TIME CURVE
    Ritzmo, Carina
    Soderhall, Stefan
    Jakobson, Ake
    Eksborg, Staffan
    PEDIATRIC BLOOD & CANCER, 2009, 53 (05) : 889 - 889
  • [8] A Bayesian Exposure-Time Method for Clinical Trial Safety Monitoring With Blinded Data
    Schnell, Patrick M.
    Ball, Greg
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2016, 50 (06) : 833 - 838
  • [9] What Is The Best Time Sampling For The Two Direct Oral Anticoagulants, Dabigatran and Rivaroxaban?
    Douxfils, Jonathan
    Classen, Jean-Francois
    Baudar, Justine
    Devalet, Berangere
    Samama, Meyer Michel
    Chatelain, Bernard
    Dogne, Jean-Michel
    Mullier, Francois
    BLOOD, 2013, 122 (21)
  • [10] A Bayesian Exposure-Time Method for Clinical Trial Safety Monitoring With Blinded Data
    Patrick M. Schnell
    Greg Ball
    Therapeutic Innovation & Regulatory Science, 2016, 50 : 833 - 838
12345